New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Penn Study Illuminates Why Cancers Caused by BRCA Mutations Recur Penn Medicine News News | November 2022 Research Groups Across the US Testing Vaccines to Help Prevent, Terminate Cancer ABC10 News San Diego News | October 2022 For Patients with Earliest Stage of Breast Cancer, How Much Treatment is Enough? USA Today News | October 2022 What’s the BRCA Gene, and How Does It Affect Breast Cancer? Katie Couric Media News | October 2022 Groundbreaking Study to Test a Breast Cancer Vaccine Fox29 News | October 2022 After Giving Up on Cancer Vaccines, Doctors Start to Find Hope The New York Times News | October 2022 The Race to Make a Vaccine for Breast Cancer TIME News | October 2022 Mindy and Jon Gray Gift $55M to Penn’s Basser Center for BRCA for Cancer Interception Institute The Cancer Letter News | September 2022 Integrating Genetic Testing in Electronic Health Records Saves Time, Penn Study Finds Penn Medicine News News | September 2022 University Of Pennsylvania Receives $55 Million Gift To Study, Treat Hereditary Cancers Forbes News | September 2022 $55 Million Gift Creates New “Cancer Interception” Institute at Penn’s Basser Center for BRCA to Stop Hereditary Cancers at the Earliest Stages Penn Medicine News News | September 2022 $55 Million Gift to Penn is Aimed at Stopping Breast Cancer Before It Starts The Philadelphia Inquirer News | September 2022 Blackstone’s Gray Gives UPenn $55 Million for Cancer Prevention Bloomberg News | September 2022 Penn Receives $55M Gift from Blackstone President Toward Breast Cancer Research Philadelphia Business Journal News | September 2022 A Universal Drug Target for Ovarian Cancer Drug Discovery News News | August 2022 Study Shows High Rate of Actionable Mutations in Lung Cancer MedPage Today News | August 2022 Breast Cancer Drug Trial Results in "Unheard-Of" Survival The New York Times News | June 2022 How A Genetic Test Saved This Black Woman’s Life Essence News | April 2022 Pagination First page« First Previous page‹‹ … Page4 Page5 Page6 Page7 Current page8 Page9 Page10 Page11 Page12 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Penn Study Illuminates Why Cancers Caused by BRCA Mutations Recur Penn Medicine News News | November 2022
Research Groups Across the US Testing Vaccines to Help Prevent, Terminate Cancer ABC10 News San Diego News | October 2022
For Patients with Earliest Stage of Breast Cancer, How Much Treatment is Enough? USA Today News | October 2022
After Giving Up on Cancer Vaccines, Doctors Start to Find Hope The New York Times News | October 2022
Mindy and Jon Gray Gift $55M to Penn’s Basser Center for BRCA for Cancer Interception Institute The Cancer Letter News | September 2022
Integrating Genetic Testing in Electronic Health Records Saves Time, Penn Study Finds Penn Medicine News News | September 2022
University Of Pennsylvania Receives $55 Million Gift To Study, Treat Hereditary Cancers Forbes News | September 2022
$55 Million Gift Creates New “Cancer Interception” Institute at Penn’s Basser Center for BRCA to Stop Hereditary Cancers at the Earliest Stages Penn Medicine News News | September 2022
$55 Million Gift to Penn is Aimed at Stopping Breast Cancer Before It Starts The Philadelphia Inquirer News | September 2022
Penn Receives $55M Gift from Blackstone President Toward Breast Cancer Research Philadelphia Business Journal News | September 2022
